Fluvoxamine for the Early Treatment of SARS-CoV-2 Infection: A Review of Current Evidence. Facente SN, Reiersen AM, Lenze EJ, Boulware DR, et al. Drugs 2021;81:2081-2089.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Facente SN, Reiersen AM, Lenze EJ, Boulware DR, et al. Fluvoxamine for the Early Treatment of SARS-CoV-2 Infection: A Review of Current Evidence. Drugs 2021;81:2081-2089.
PMID: 34851510